Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Return on Assets (2020 - 2025)

Historic Return on Assets for Keros Therapeutics (KROS) over the last 6 years, with Q3 2025 value amounting to 0.09%.

  • Keros Therapeutics' Return on Assets rose 4500.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 4500.0%. This contributed to the annual value of 0.38% for FY2024, which is 700.0% up from last year.
  • Keros Therapeutics' Return on Assets amounted to 0.09% in Q3 2025, which was up 4500.0% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Keros Therapeutics' Return on Assets registered a high of 0.09% during Q3 2025, and its lowest value of 0.49% during Q4 2023.
  • For the 5-year period, Keros Therapeutics' Return on Assets averaged around 0.28%, with its median value being 0.34% (2022).
  • Per our database at Business Quant, Keros Therapeutics' Return on Assets tumbled by -1300bps in 2022 and then skyrocketed by 4500bps in 2025.
  • Keros Therapeutics' Return on Assets (Quarter) stood at 0.24% in 2021, then crashed by -55bps to 0.37% in 2022, then tumbled by -30bps to 0.49% in 2023, then soared by 36bps to 0.31% in 2024, then surged by 127bps to 0.09% in 2025.
  • Its Return on Assets was 0.09% in Q3 2025, compared to 0.02% in Q2 2025 and 0.01% in Q1 2025.